Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows

v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities    
Net loss $ (51,726) $ (60,839)
Impairment of Long-Lived Assets to be Disposed of   919
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 23,781 24,343
Stock-based compensation 15,995 16,263
Foreign currency transaction loss (gain) 2,934 1,967
Share in net (profits) losses of associated companies 243 7,343
Unrealized Gain (Loss) on Investments 3,065 1,217
Acquisitions 1,034  
Deferred income taxes, net and uncertain tax positions 369 2,810
Other non-cash items, net 761 2,073
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net 18,829 (11,156)
Inventories (2,783) (11,161)
Other current assets and prepaid expenses 5,900 (3,777)
Other non-current assets 3,049 4,642
Accounts payable 2,839 (4,360)
Other current liabilities (7,323) (8,972)
Deferred revenues (5,805) 3,715
Other non-current liabilities (6,261) (6,194)
Net cash provided by (used in) operating activities 4,901 (41,167)
Cash flows from investing activities    
Cash paid for business combinations, net of cash acquired 0 (66,472)
Purchase of property and equipment (4,807) (6,546)
Investments in short-term bank deposits (50,000) (12,448)
Proceeds from sale of equity method investment 50,000 128,815
Purchase of intangible assets (1,142) (464)
Other investing activities (147) (58)
Payments to Acquire Long-Term Investments (8,845) (6,199)
Net cash used in investing activities (14,941) 36,628
Cash flows from financing activities    
Proceeds from exercise of stock options 153 9
Payment of contingent consideration (1,037) (691)
Other financing activities 183 0
Net cash provided by (used in) financing activities (701) (682)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (987) (824)
Net change in cash, cash equivalents and restricted cash (11,728) (6,045)
Cash, cash equivalents and restricted cash, beginning of year 82,864 150,686
Cash, cash equivalents and restricted cash, end of year 71,136 144,641
Non-cash investing and financing activities:    
Transfer of inventories to fixed assets 1,658 5,612
Transfer of fixed assets to inventories 4,841 118
Stock Issued During Period, Value, Employee Stock Purchase Plan 3,264 3,014
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability   3,009
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 70,858 144,366
Restricted cash included in other current assets 278 275
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total $ 71,136 $ 144,641